177 related articles for article (PubMed ID: 10775732)
21. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.
Mourits MJ; Hollema H; De Vries EG; Ten Hoor KA; Willemse PH; Van Der Zee AG
Hum Pathol; 2002 Mar; 33(3):341-6. PubMed ID: 11979376
[TBL] [Abstract][Full Text] [Related]
23. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
24. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
Salmi A; Pakarinen P; Peltola AM; Rutanen EM
Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
[TBL] [Abstract][Full Text] [Related]
26. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.
Kavak ZN; Binöz S; Ceyhan N; Pekin S
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963
[TBL] [Abstract][Full Text] [Related]
27. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
28. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
29. Tamoxifen and the endometrium.
Barakat RR
Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
[No Abstract] [Full Text] [Related]
30. Effects of tamoxifen on endometrial estrogen and progesterone receptor concentrations in women with fibrocystic disease of the breast.
Pérez-López FR; Blasco Comenge C
Gynecol Endocrinol; 1993 Sep; 7(3):185-9. PubMed ID: 8291456
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
Duffy SR; Taylor L
Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
[TBL] [Abstract][Full Text] [Related]
34. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen induction of angiogenic factor expression in endometrium.
Hague S; Manek S; Oehler MK; MacKenzie IZ; Bicknell R; Rees MC
Br J Cancer; 2002 Mar; 86(5):761-7. PubMed ID: 11875740
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study.
Gielen SC; Kühne LC; Ewing PC; Blok LJ; Burger CW
Endocr Relat Cancer; 2005 Dec; 12(4):1037-49. PubMed ID: 16322341
[TBL] [Abstract][Full Text] [Related]
37. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells.
Helmestam M; Andersson H; Stavreus-Evers A; Brittebo E; Olovsson M
Am J Pathol; 2012 Jun; 180(6):2527-35. PubMed ID: 22531128
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
40. Alterations in steroid hormone receptors in the tamoxifen-treated endometrium.
Schwartz LB; Krey L; Demopoulos R; Goldstein SR; Nachtigall LE; Mittal K
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):129-37. PubMed ID: 9024103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
